Following Highest Single Day Death UK Speeds Up COVID-19 Vaccination Drive by Pooja Shete on January 25, 2021 at 11:07 PM
UK saw the highest single-day death total which has increased the need to speed up mass vaccination program against COVID-19. Many programs have started in the UK which has aimed to both stop the rampant spread of the outbreak as well as to pull the country out of a third national lockdown. UK is hoping to vaccinate the highest-risk populations by the end of spring.
Considering the current situation of the outbreak, these programs may be the nation s only hope to resolve this dire situation.
COVID-19 Vaccination Centers to Increase to 225 in a Week by Angela Mohan on January 15, 2021 at 12:37 PM
New Delhi government is expecting to increase the number of vaccination centres to 225 within a week of the COVID-19 immunization programme launch.
Dr Suneela Garg, member of the task force for COVID vaccination confirmed to IANS that the government is looking to extend the sites by the week of immunization drive launch. We may have close to 225 centres. Eventually, we have demarcated 1,000 centres and will be spawning over them gradually, she said.
The massive inoculation drive slated to begin January 16 onwards will be launched in Delhi with 81 hospitals, Chief Minister Arvind Kejriwal informed earlier in the day.
Mental Health Issues Dampen Efficacy of COVID-19 Vaccines by Colleen Fleiss on January 14, 2021 at 11:09 PM
Fortunately, it may be possible to reduce these negative effects with simple steps like exercise and sleep.
Vaccines are among the safest and most effective advances in medical history, protecting society from a wide range of otherwise devastating diseases, including smallpox and polio. The key to their success, however, is ensuring that a critical percentage of the population is effectively vaccinated to achieve so-called herd immunity.
‘Depression and stress could dampen the efficacy of COVID-19 vaccines.’
Even though rigorous testing has shown that the COVID-19 vaccines approved for distribution in the United States are highly effective at producing a robust immune response, not everyone will immediately gain their full benefit. Environmental factors, as well as an individual s genetics and physical and mental health, can weaken the body s im
Rapid Antibody Testing For COVID-19 by Pooja Shete on January 11, 2021 at 12:43 PM
An advanced nanomaterial-based biosensing platform has been found by the researchers that detects antibodies specific to SARS-CoV-2, the virus responsible for the COVID-19 pandemic within seconds. Additional to testing, this platform will help to quantify patient immunological response to the new vaccines with precision.
The study conducted by researchers at Carnegie Mellon University in collaboration with University of Pittsburgh (Pitt) and the UPMC is published in the journal
Advanced Materials.
The testing platform identified the presence of two virus antibodies- spike S1 protein and receptor binding domain (RBD), in a very small drop of blood. Antibody concentrations can also be detected in low concentrations and this detection happens through an electrochemical reaction within a handheld microfluidic device which sends results almost immediately to a simple interface o
COVID-19 Vaccine Of Moderna Shows Good Efficacy In Clinical Trials by Pooja Shete on January 1, 2021 at 7:27 PM
Data from the much-anticipated COVE study, which evaluated mRNA-1273, a vaccine candidate against COVID-19 manufactured by Moderna, Inc, provides evidence that the vaccine can prevent symptomatic infection. The study will continue for two years more.
The trial which evaluated more than 30,000 participants randomized to receive the vaccine or a placebo showed that 11 participants in the vaccine group developed symptomatic COVID-19 when compared to 185 participants who received the placebo. The vaccine showed an efficacy of 94.1 percent in preventing symptomatic COVID-19. Only in one participant a severe case of COVID-19 was seen.